Novo Seeds invests in Dermtreat
Dermtreat raises USD 17.7 million from from Sofinnova Ventures, Novo A/S and Lundbeckfonden.
Copenhagen, Denmark – May 8, 2017: Danish-based Dermtreat today announced the successful closure of a USD 17.7 mill. Series A financing led by the US-based leading venture capital firm, Sofinnova, with the leading Nordic venture capital firms Novo Seeds and Lundbeckfonden Emerge in the syndicate. Existing shareholders are also participating.